Best Genomics Companies in Florida, United States
The 77 best Genomics companies in Florida, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: NeoGenomics.
Our analysis of 50 Genomics companies
$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Genomics companies in Florida
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | NeoGenomics Provider of cancer genetic diagnostic services | $446M | 65 mo ago | 2,100 2,100 → 1,793 (-15%) | 2002 | — | SentryBugHerdApple iCloud Mail+20 | — | — |
| 2 | Lakewood-Amedex Developer of nano RNA gene silencing platform to develop targeted therapeutics for viral infections | $36M | 65 mo ago | 11 | 2006 | Steve Parkinson CEO | WordPressMySQLPHP+20 | 148 patents Patents concentrated in health & consumer products | 2 launchs |
| 3 | Lacerta Therapeutics Developer of adeno-associated virus for CNS diseases | $33M | 81 mo ago | 43 | 2015 | — | — | — | — |
| 4 | InflammX Therapeutics Developer of therapeutics for ophthalmic disorders | $29M | 65 mo ago | 2 | 2005 | Colin Green Co-Founder | — | — | — |
| 5 | GeneTx Developer of a antisense oligonucleotide for treating a rare genetic disorder | $20M | 82 mo ago | — | 2017 | Allyson Berent Co-Founder & COO | — | — | — |
| 6 | InformedDNA Provider of network of genetics experts to help patients and providers | $19M | 78 mo ago | 124 | 2007 | — | WordPressMySQLPHP+27 | — | 2 job openings |
| 7 | NanoVir Developer of DNA-targeting therapeutics to treat HPV | $12M | 191 mo ago | — | 2003 | Chris Fisher Co-Founder | — | 33 patents Antiviral small molecules and DNA‑binding polyamides for treating dsDNA viruses, especially HPV | — |
| 8 | PositiveID Corporation Developer of biological detection and diagnostics solutions | $11M | 161 mo ago | 30 | 2001 | — | — | 4 patents Portable wireless chemical sensors for real-time acetone detection in gas streams | — |
| 9 | Firebird Biomolecular Sciences Provider of modified DNA as reagents for research, synthetic biology, and diagnostics | $7M | 17 mo ago | 9 | 2005 | Steven Benner Founder | — | — | — |
| 10 | InteGen Provider of cytogenetics, DNA FISH probes for research application | $5M | 92 mo ago | 4 | 2011 | Ramesh Babu Founder & CEO | — | — | — |
| 11 | Cytonics Developer of biologic therapies targeting molecular drivers of cartilage degradation | $3M | 84 mo ago | 8 | 2006 | Gaetano Scuderi Founder & President | WordPressMySQLPHP+43 | 66 patents Engineered alpha-2-macroglobulin biologics for regenerative therapies and transplantation support | — |
| 12 | Mel-Mont Medical Developer of molecular screening devices for the early detection of infectious diseases | $3M | 6 mo ago | 4 | 2014 | Frank Melendez Co-Founder & CEO | — | — | — |
| 13 | VuEssence Genome based diagnostic technology platform | $3M | 13 mo ago | 5 | 2010 | Maha Sallam Founder & President | — | 2 patents Neurovascular disease diagnostics and gene‑expression‑targeted therapeutics | — |
| 14 | Deluge Biotechnologies Developer of peptide-inspired constrained oligomers for the synthesis and screening of DNA-encoded | $2M | 15 mo ago | 15 | 2017 | Thomas Kodadek Co-Founder | — | — | — |
| 15 | MicroGen Diagnostics Provider of sequencing and molecular diagnostic services | $2M | 110 mo ago | 142 | 2011 | Randall Wolcott Founder | Cart FunctionalityWooCommerceWordPress+32 | — | — |
| 16 | MDNA Life Sciences Provider of genomic and molecular diagnostics based on the mitochondrial genome | $1M | 89 mo ago | 8 | 2001 | — | — | — | — |
| 17 | Soilcea Developing HLB-resistant citrus trees using CRISPR technology for Florida's citrus industry | $750K | 15 mo ago | 3 | 2014 | Chana Cannon Co-Founder & VP | WordPress Block EditorWordPressMySQL+9 | — | — |
| 18 | Cvergenx Genomic informatics company personalizing radiation therapy with precision genomic radiation therapy platform | $616K | 126 mo ago | 3 | 2009 | — | — | 10 patents Genomics-driven personalized radiation therapy planning and dosing for head‑and‑neck cancers | — |
| 19 | Integrated Plant Genetics Provider of genetic technologies for plant development and resistance | $566K | 133 mo ago | — | 1998 | Dean W Gabriel Founder & President | — | 39 patents RNAi and nano-formulated agrochemicals for controlling bacterial, fungal, and vector-borne plant diseases | — |
| 20 | Rapid Genomics Provider of DNA sequencing services for the improvement of crops and livestocks | $300K | 128 mo ago | 30 | 2011 | — | — | 20 patents Targeted high-throughput DNA sequencing and genomic region capture technologies. | — |
| 21 | GeneLink BioSciences Genome-based nutritional supplements | $105K | 158 mo ago | 15 | 1994 | Robert Ricciardi Founder | — | — | — |
| 22 | Parallel Testing App offering medication information | $100K | 110 mo ago | 4 | 2015 | Cathy Cather CEO | — | — | — |
Top 12 Genomics companies in Florida
#1
Series A · Doral, Florida · founded 2014 · 4 employees$3Mraised▾
Developer of molecular screening devices for the early detection of infectious diseases. The company develops a diversified portfolio of proprietary technologies and medical devices for the early identification of DNA and RNA virus-related pathologies. The product portfolio includes XytoTest and Anal test for cervical cancer, and HR-HPV DNA detection. Also, offers in-vitro diagnostic tests for the detection of HPV infections.
- Dec 2025Series A$250K
- Aug 2023Series A$6.9M
- Nov 2020Seed$3M
#2
Funding Raised · Gainesville, Florida · founded 2005 · 9 employees$7.3Mraised▾
Provider of modified DNA as reagents for research, synthetic biology, and diagnostics. The company's products include reversible terminators (oxime blocked and disulfide-linked tags), artificially expanded genetic information systems, modified nucleosides, phosphoramides, triphosphates, and polymerases, and Self-Avoiding Molecular Recognition Systems (a species of DNA that can bind via simple rules to natural DNA but cannot bind to other members of the same SAMRS species), Universal (TM) nucleotides, SNAP2 (TM) Oligonucleotides for high specificity and high discrimination binding of primers, and selenium-containing phosphoramidites that help speed up crystallization of oligonucleotides.
- Jan 2025Grant (prize money)$243.2K
- Feb 2022Grant (prize money)$243.2K
- Apr 2021Grant (prize money)$258.9K
- Sep 2017Grant (prize money)$136.4K
#3
Seed · Tampa, Florida · founded 2010 · 5 employees$2.7Mraised▾
VuEssence is developing diagnostic technology platforms for the treatment of stroke and neurological conditions. The company is developing diagnostic devices which use molecular analysis based on human genome and transcriptome data for the detection and management of stroke.
- Apr 2025Seed$47.5K
- Mar 2018Seed$1.5M
- May 2016Seed$1.2M
#4
Funding Raised · Jupiter, Florida · founded 2017 · 15 employees$1.7Mraised▾
Developer of peptide-inspired constrained oligomers for the synthesis and screening of DNA-encoded. The company uses macrocyclic PICCO molecules that involved in the binding process of protein-protein interaction regions and allosteric sites. It also uses a novel FACS-based technology that maintains each molecule in the library & promotes isolation of selective ligands.
- Mar 2025Grant (prize money)$1.5M
- Mar 2025Grant (prize money)$265.5K
#5
Seed · Tampa, Florida · founded 2014 · 3 employees$750Kraised▾
Developing HLB-resistant citrus trees using CRISPR technology for Florida's citrus industry. This innovative company focuses on restoring the natural defenses of citrus trees against Huanglongbing (HLB), a devastating disease. Through precision breeding and collaboration with the University of Florida, they are creating new citrus varieties that exhibit reduced disease levels and vigorous growth. Their technology offers a breakthrough solution for citrus growers, aiming to revitalize the industry and mitigate the economic impact of HLB. This research and development company is committed to sustainable agriculture and offers a potential social impact by preserving a vital agricultural sector. They leverage gene editing to improve crop resilience and promote healthier citrus production.
- Mar 2025Grant (prize money)$650K
- Feb 2024Seed$500K
- Jun 2018Seed$250K
#6
Public · Fort Myers, Florida · founded 2002 · 2100 employees$445.5Mraised▾
Provider of cancer genetic diagnostic services. The company operates a network of cancer-focused testing labs, which is engaged in providing testing services to pathologists, oncologists, and other laboratories. The company provides services for cancer cytogenetics, hematologic and solid tumor FISH testing, 10-color flow cytometry, and nearly 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker tests in the industry.
- Jan 2021Post IPO$345M
- Jun 2019Conventional Debt$100M
- Mar 2009Post IPO$500K
#7
Public · Sarasota, Florida · founded 2006 · 11 employees$36.2Mraised▾
Developer of nano RNA gene silencing platform to develop targeted therapeutics for viral infections. The company's lead nanoRNA product, Influ-RNA, is an anti-influenza agent. The company is also developing drugs and has lead candidates for pneumonia in cystic fibrosis patients, chronic wounds, chronic otitis media, and implant- and catheter-associated infections.
- Jan 2021Series C$24.1M
- Sep 2015Series C$6.6M
- Jun 2014Series C$5.5M
#8
Series B · Tampa, Florida · founded 2005 · 2 employees$28.5Mraised▾
Developer of therapeutics for ophthalmic disorders. It offers Xiflam an orally administered NLRP3 inflammasome inhibitor to inhibit the pathological Cx43 hemichannel and modulate the activation of the inflammasome. It is focused on the ophthalmic indications of diabetic macular edema, age-related macular degeneration, and geographic atrophy.
- Jan 2021Series B$9.1M
- Jul 2012Series B$19.4M
#9
Deadpooled · Alachua, Florida · founded 2015 · 43 employees$32.8Mraised▾
Lacerta Therapeutics is a developer of adeno-associated virus (AAV) vectors for treating CNS diseases and lysosomal storage diseases. The company has developed proprietary capsid variants and scalable vector manufacturing platform. It has developed AAV gene therapies for Pompe disease, Sanfilippo syndrome type B, aromatic L-amino acid decarboxylase deficiency, neurodegenerative proteinopathies, spinocerebellar ataxia, and glioblastoma.
- Sep 2019Grant (prize money)$2.5M
- Aug 2018Series A$30M
- Jun 2017Seed$500K
- Seed$2.3M
#10
Series A · St Petersburg, Florida · founded 2007 · 124 employees$19.2Mraised▾
Provider of network of genetics experts to help patients and providers. The website provides information about the genetic counseling services provided by InformedDNA to both consumers and medical providers and allows them to book an appointment.
- Dec 2019Series A—
- Dec 2019Conventional Debt$10M
- Mar 2016Series A$6.5M
- Jul 2014Seed$5M
#11
Acquired · Sarasota, Florida · founded 2017$20Mraised▾
GeneTx Biothereputics (a subsidiary of the Foundation for Angelman Syndrome Therapeutics) is developing therapeutics for treating Angelman syndrome (AS). The company has developed GTX-102, an antisense oligonucleotide which is used for targeted therapy for treating the rare genetic disorder that causes developmental delay, impaired motor function, loss of speech, and epilepsy.
- Aug 2019Series A$20M
#12
Deadpooled · Delray Beach, Florida · founded 2001 · 30 employees$10.9Mraised▾
Developer of biological detection and diagnostics solutions. The company focused on the development of microfluidic systems M-BAND (Microfluidic Bio-agent Autonomous Networked Detector) that analyzes air samples for the detection of biological airborne threats in the form of bacteria, viruses, and toxins.
- Jan 2013Series A$1.1M
- Aug 2011Series A$1.5M
- May 2011Series A$950K
- Mar 2011Series A$4.7M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Genomics coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics in Florida is moving
A read on the academic research around Bioinformatics in Florida — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 309 papers.
- University of Florida108
- Mayo Clinic in Florida80
- Florida College40
- University of South Florida32
- Florida State University22
- Gene1→11
- RNA editing1→4
- Immune system1→4
- Sequence (biology)1→3
- Disease2→17
- Gene1→10
- Transcriptome1→7
- Disease9
- Microbiome7
- Cancer5
- MEDLINE4
- Adverse effect4
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.